Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
E-cadherin and fibronectin expressions lacked prognostic value in breast cancer
September 29th, 2005
The expressions of E-cadherin (EC) and fibronectin (FN) did not hold prognostic significance in breast cancer. According to a study from Poland, "The aim of the study was to describe the expressions of EC and FN and their prognostic value in radically treated ductal breast cancer. Ninety-eight patients, aged 26-86 (median, 57) with stage II G2 or G3 tumors, were subjected to a retrospective analysis." "No significant associations were observed between the levels of the proteins studied and patient or cancer features, with the exception of relationships between FN expression and the histological grade of the tumor or hormonal status of the subjects....
Source: Women's Health Weekly (2005-09-29)
|
